We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$415M
AUM Growth
+$17.2M
Cap. Flow
-$15.8M
Cap. Flow %
-3.8%
Top 10 Hldgs %
43.54%
Holding
60
New
2
Increased
7
Reduced
37
Closed
2

Top Buys

Rank Stock Value
1
HSIC icon
Henry Schein
HSIC
+$5.39M
2
AVGO icon
Broadcom
AVGO
+$4.99M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.24M
4
UNH icon
UnitedHealth
UNH
+$1.9M
5
TFC icon
Truist Financial
TFC
+$1.78M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$5.83M
2
ZBRA icon
Zebra Technologies
ZBRA
+$3.75M
3
ULTA icon
Ulta Beauty
ULTA
+$3.48M
4
KEYS icon
Keysight
KEYS
+$3.06M
5
PEP icon
PepsiCo
PEP
+$2.88M

Sector Composition

Rank Sector Weight
1 Technology 25.17%
2 Healthcare 18.58%
3 Financials 15.29%
4 Consumer Staples 12.54%
5 Consumer Discretionary 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AOS icon
26
A.O. Smith
AOS
$8.17B
$6.68M 1.61%
74,725
-2,071
-3% -$171K
GNTX icon
27
Gentex
GNTX
$4.97B
$5.9M 1.42%
163,419
-4,784
-3% -$166K
SEIC icon
28
SEI Investments
SEIC
$12.4B
$5.85M 1.41%
81,311
-3,119
-4% -$207K
WTW icon
29
Willis Towers Watson
WTW
$31.2B
$5.77M 1.39%
20,970
– –
KO icon
30
Coca-Cola
KO
$377B
$5.73M 1.38%
93,720
– –
OTIS icon
31
Otis Worldwide
OTIS
$27.4B
$5.54M 1.33%
55,817
-945
-2% -$87.3K
LHX icon
32
L3Harris
LHX
$51.6B
$5.28M 1.27%
24,779
-437
-2% -$91.8K
AON icon
33
Aon
AON
$76.5B
$5.04M 1.21%
15,110
-395
-3% -$122K
ULTA icon
34
Ulta Beauty
ULTA
$22B
$4.97M 1.2%
9,496
-6,746
-42% -$3.48M
CME icon
35
CME Group
CME
$96.3B
$4.83M 1.16%
22,416
+3,786
+20% +$795K
CDW icon
36
CDW
CDW
$18.9B
$4.69M 1.13%
18,349
-775
-4% -$184K
UNP icon
37
Union Pacific
UNP
$174B
$3.94M 0.95%
16,023
-435
-3% -$107K
WMT icon
38
Walmart Inc
WMT
$885B
$3.6M 0.87%
59,850
– –
V icon
39
Visa
V
$684B
$3.12M 0.75%
11,179
-239
-2% -$66K
SONY icon
40
Sony
SONY
$137B
$3.07M 0.74%
178,885
-3,140
-2% -$57.7K
EXPE icon
41
Expedia Group
EXPE
$35.4B
$3.03M 0.73%
21,983
-540
-2% -$76.8K
NVS icon
42
Novartis
NVS
$297B
$2.41M 0.58%
24,910
-546
-2% -$56K
ABBV icon
43
AbbVie
ABBV
$443B
$2.23M 0.54%
12,242
– –
PFE icon
44
Pfizer
PFE
$143B
$1.92M 0.46%
69,262
-1,262
-2% -$35K
PEP icon
45
PepsiCo
PEP
$190B
$1.58M 0.38%
9,028
-17,112
-65% -$2.88M
SNY icon
46
Sanofi
SNY
$103B
$1.55M 0.37%
31,916
-913
-3% -$44.6K
ABT icon
47
Abbott
ABT
$183B
$1.39M 0.33%
12,200
– –
UL icon
48
Unilever
UL
$137B
$966K 0.23%
17,106
-538
-3% -$29.8K
KHC icon
49
Kraft Heinz
KHC
$30.7B
$680K 0.16%
18,418
– –
PG icon
50
Procter & Gamble
PG
$336B
$573K 0.14%
3,532
– –
1
2
3

Similar funds

HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
PAMS
Pinpoint Asset Management (Singapore) Singapore $433M AUM 32.19% 1-Year Est. Return
SSWG
Seven Springs Wealth Group Brentwood, Tennessee $432M AUM 23% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Foyston, Gordon, & Payne's Q1 2024 Portfolio in Review

As of Q1 2024, Foyston, Gordon, & Payne held 60 positions worth $415M, up 4.3% from $398M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $15.8M in Q1 2024, closing 2 positions and reducing 37 holdings. Its most notable exit was Humana, an estimated $5.83M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Foyston, Gordon, & Payne opened a new position in Eagle Materials worth $254K.

  • Foyston, Gordon, & Payne's largest Q1 2024 buy was Eagle Materials: 933 shares worth $254K.
  • Foyston, Gordon, & Payne added most to Henry Schein in Q1 2024, an estimated $5.39M increase.
  • Foyston, Gordon, & Payne's biggest Q1 2024 reduction was Zebra Technologies, cutting an estimated $3.75M.
  • Foyston, Gordon, & Payne fully exited Humana in Q1 2024, selling an estimated $5.83M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 44% of its $415M portfolio in Q1 2024.
  • Foyston, Gordon, & Payne opened 2 new positions and closed 2 in Q1 2024.
  • Foyston, Gordon, & Payne's portfolio value rose 4.3% quarter-over-quarter to $415M.

Based on Foyston, Gordon, & Payne's 13F filing for Q1 2024, filed 7 May 2024.